Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Product Information Update- Orap (pimozide) 4mg Tablets
Notice type:
3rd Party Publications
Date:
25/02/2016
Notification of withdrawal from market for commercial reasons
Product name or type:
Orap (pimozide) 4mg Tablets
Authorisation Holder:
Janssen-Cilag Limited (Janssen)
Further Information:
Product Information Update- Orap (pimozide) 4mg Tablets
« Back
Date Printed: 14/05/2024